In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors

Jiang Y, Liu L, Manning M, Bonahoom M, Lotvola A, Yang Z-Q. Repurposing Therapeutics to Identify Novel Inhibitors Targeting 2’-O-Ribose Methyltransferase Nsp16 of SARS-CoV-2. ChemRxiv. Published online 2020. doi:10.26434/chemrxiv.12252965. Chen, 2011, Biochemical and structural insights into the mechanisms of sars coronavirus RNA ribose 2′-O-methylation by nsp16/nsp10 protein complex, PLoS Pathog, 7, 10.1371/journal.ppat.1002294 Decroly, 2011, Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-o-methyltransferase nsp10/nsp16 complex, PLoS Pathog, 7, 10.1371/journal.ppat.1002059 Aouadi, 2017, Binding of the methyl donor S-Adenosyl-l-Methionine to Middle East respiratory syndrome coronavirus 2′-O-methyltransferase nsp16 promotes recruitment of the allosteric activator nsp10, J Virol, 91, 10.1128/JVI.02217-16 Menachery, 2014, Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments, Virus Res, 194, 191, 10.1016/j.virusres.2014.09.009 Subissi, 2014, SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets, Antivir Res, 101, 122, 10.1016/j.antiviral.2013.11.006 Sevajol, 2014, Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus, Virus Res, 194, 90, 10.1016/j.virusres.2014.10.008 Menachery, 2014, Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2’-O-methyltransferase activity, J Virol, 88, 4251, 10.1128/JVI.03571-13 Rosas-Lemus, 2020, High-resolution structures of the SARS-CoV-2 2′-O-methyltransferase reveal strategies for structure-based inhibitor design, Sci Signal, 13, 10.1126/scisignal.abe1202 Fuzimoto, 2020, The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - additional weapons in the fight against the COVID-19 pandemic?, J Tradit Compl Med, 10, 405, 10.1016/j.jtcme.2020.05.003 Omrani, 2021, Potential natural products against respiratory viruses: a perspective to develop anti-COVID-19 medicines, Front Pharmacol, 11, 2115, 10.3389/fphar.2020.586993 Pandey, 2020, Natural plant products: a less focused aspect for the COVID-19 viral outbreak, Front Plant Sci, 11, 1356, 10.3389/fpls.2020.568890 Prasansuklab, 2021, Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection, J Tradit Compl Med, 11, 144, 10.1016/j.jtcme.2020.12.001 Chowdhury, 2020, Tea bioactive modulate innate immunity: in perception to COVID-19 pandemic, Front Immunol, 11, 1, 10.3389/fimmu.2020.590716 Mhatre, 2021, Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review, Phytomedicine, 85, 153286, 10.1016/j.phymed.2020.153286 Khan, 2013, Tea and health: studies in humans, Curr Pharmaceut Des, 19, 6141, 10.2174/1381612811319340008 Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. Published online May 13, 2020:1-10. doi:10.1080/07391102.2020.1766572. Bhardwaj, 2021, Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs, Comput Biol Med, 128, 10.1016/j.compbiomed.2020.104117 Ghosh R, Chakraborty A, Biswas A, Chowdhuri S. Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches. J Biomol Struct Dyn. Published online December 9, 2020:1-12. doi:10.1080/07391102.2020.1858164. Sharma J, Kumar Bhardwaj V, Singh R, Rajendran V, Purohit R, Kumar S. An in-silico evaluation of different bioactive molecules of Tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chem. Published online 2020:128933. doi:10.1016/j.foodchem.2020.128933. Ohgitani, 2020, Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro, bioRxiv, 12 Du, 2021, Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2, Int J Biol Macromol, 176, 1, 10.1016/j.ijbiomac.2021.02.012 Bhardwaj, 2021, Bioactive molecules of Tea as potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2, Front Med, 8, 645, 10.3389/fmed.2021.684020 Umashankar, 2021, Phytochemical moieties from Indian traditional medicine for targeting dual hotspots on SARS-CoV-2 spike protein: an integrative in-silico approach, Front Med, 8, 10.3389/fmed.2021.672629 Krafcikova, 2020, Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin, Nat Commun, 11, 10.1038/s41467-020-17495-9 Nakai, 2005, Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro, J Agric Food Chem, 53, 4593, 10.1021/jf047814+ Namal Senanayake SPJ, 2013, Green tea extract: Chemistry, antioxidant properties and food applications - a review, J Funct Foods, 5, 1529, 10.1016/j.jff.2013.08.011 Studio D. Dassault Systemes BIOVIA, Discovery Studio Modelling Environment, Release 4.5. Accelrys Softw Inc. Published online 2015:98-104. Zheng, 2017, Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians, J Chem Theor Comput, 13, 6424, 10.1021/acs.jctc.7b00719 Brooks, 1983, CHARMM: a program for macromolecular energy, minimization, and dynamics calculations, J Comput Chem, 4, 187, 10.1002/jcc.540040211 Van Der Spoel, 2005, GROMACS: fast, flexible, and free, J Comput Chem, 26, 1701, 10.1002/jcc.20291 Schüttelkopf, 2004, PRODRG: a tool for high-throughput crystallography of protein-ligand complexes, Acta Crystallogr Sect D Biol Crystallogr, 60, 1355, 10.1107/S0907444904011679 Abraham, 2011, Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5, J Comput Chem, 32, 2031, 10.1002/jcc.21773 Hess, 1997, LINCS: a linear Constraint solver for molecular simulations, J Comput Chem, 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Berendsen, 1995, GROMACS: a message-passing parallel molecular dynamics implementation, Comput Phys Commun, 91, 43, 10.1016/0010-4655(95)00042-E Kumari, 2014, G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations, J Chem Inf Model, 54, 1951, 10.1021/ci500020m Encinar, 2020, Potential drugs targeting early innate immune evasion of SARS-coronavirus 2 via 2’-O-Methylation of Viral RNA, Viruses, 12, 525, 10.3390/v12050525 Romano, 2020, A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping, Cells, 9, 1267, 10.3390/cells9051267 Panyod, 2020, Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective, J Tradit Compl Med, 10, 420, 10.1016/j.jtcme.2020.05.004 Elgazar, 2019, Insights on the molecular mechanism of anti-inflammatory effect of formula from Islamic traditional medicine: an in-silico study, J Tradit Compl Med, 9, 353, 10.1016/j.jtcme.2018.09.004 Zaki AA, Ashour A, Elhady SS, Darwish KM, Al-Karmalawy AA. Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: molecular docking, molecular dynamics, and SAR studies. J Tradit Compl Med. Published online May 17, 2021. doi:10.1016/j.jtcme.2021.05.001. Rahman, 2021, Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins, J Tradit Compl Med, 11, 173, 10.1016/j.jtcme.2021.01.006 Rangsinth, 2021, Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: an in silico approach, J Tradit Compl Med, 11, 158, 10.1016/j.jtcme.2020.12.002 Vardhan S, Sahoo SK. Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. J Tradit Compl Med. Published online April 12, 2021. doi:10.1016/j.jtcme.2021.04.001. Parashar A, Shukla A, Sharma A, Behl T, Goswami D, Mehta V. Reckoning γ-Glutamyl-S-allylcysteine as a potential Main protease (M pro ) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Drug Dev Ind Pharm. Published online May 26, 2021:1-32. doi:10.1080/03639045.2021.1934857. Zaki, 2020, Molecular docking reveals the potential of: Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease, New J Chem, 44, 16752, 10.1039/D0NJ03611K Samra, 2021, Bioassay-guided isolation of a new cytotoxic ceramide from Cyperus rotundus L, South Afr J Bot, 139, 210, 10.1016/j.sajb.2021.02.007 Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R. Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. J Biomol Struct Dyn. Published online 2021. doi:10.1080/07391102.2021.1900918. Wang, 2016, Molecular docking for drug discovery and development: a widely used approach but far from perfect, Future Med Chem, 8, 10.4155/fmc-2016-0143 Lavecchia, 2013, Virtual screening strategies in drug discovery: a critical review, Curr Med Chem, 20, 2839, 10.2174/09298673113209990001 Liang, 2021, In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex, Chem Phys Lett, 774, 10.1016/j.cplett.2021.138618 Tazikeh-Lemeski E, Moradi S, Raoufi R, Shahlaei M, Janlou MAM, Zolghadri S. Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. J Biomol Struct Dyn. Published online 2020. doi:10.1080/07391102.2020.1779133. Durrant, 2011, Molecular dynamics simulations and drug discovery, BMC Biol, 9, 10.1186/1741-7007-9-71 Salmaso, 2018, Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview, Front Pharmacol, 9, 923, 10.3389/fphar.2018.00923 Karplus, 2005, Molecular dynamics and protein function, Proc Natl Acad Sci U S A, 102, 6679, 10.1073/pnas.0408930102 Kumar Bhardwaj, 2021, Taming the ringmaster of the genome (PCNA): phytomolecules for anticancer therapy against a potential non-oncogenic target, J Mol Liq, 337, 10.1016/j.molliq.2021.116437 Bhardwaj, 2021, Computer simulation to identify selective inhibitor for human phosphodiesterase10A, J Mol Liq, 328, 10.1016/j.molliq.2021.115419 Hansson, 2002, Molecular dynamics simulations, Curr Opin Struct Biol, 12, 190, 10.1016/S0959-440X(02)00308-1 Elmaaty, 2021, Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study, RSC Adv, 11, 10027, 10.1039/D0RA10674G El Hassab, 2021, In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches, J Enzym Inhib Med Chem, 36, 727, 10.1080/14756366.2021.1885396 Bhardwaj, 2020, A new insight into protein-protein interactions and the effect of conformational alterations in PCNA, Int J Biol Macromol, 148, 999, 10.1016/j.ijbiomac.2020.01.212 Huang, 2020, An accurate free energy estimator: based on MM/PBSA combined with interaction entropy for protein-ligand binding affinity, Nanoscale, 12, 10737, 10.1039/C9NR10638C Wang, 2018, Recent developments and applications of the MMPBSA method, Front Mol Biosci, 4, 87, 10.3389/fmolb.2017.00087